Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AAVrh32.33 capsid demonstrates unexpected dermal tropism regardless of immunodominant epitope.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

A spatially coordinated keratinocyte-fibroblast circuit recruits MMP9<sup>+</sup> myeloid cells to drive type I interferon-driven inflammation in photosensitive autoimmunity.

Nature immunology·2026

Same author

Impact of treatment duration on response durability: A post hoc analysis of the double-blind, vehicle-controlled, randomized TRuE-V long-term extension study of ruxolitinib cream in vitiligo.

Journal of the American Academy of Dermatology·2026

Same author

Cancer-selective photoimmunotherapy spares T cells and NK cells and promotes antitumor immunity in an allogeneic human 3D culture model.

Photochemistry and photobiology·2026

Same author

Definition of Severity and Relapse for Vitiligo: An International Consensus Statement.

JAMA dermatology·2026

Same author

Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Same journal

An Integrated Skin Cell Atlas Decodes the Pilosebaceous Unit.

The Journal of investigative dermatology·2026

Same journal

Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

The Journal of investigative dermatology·2026

Same journal

Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

The Journal of investigative dermatology·2026

Same journal

Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

The Journal of investigative dermatology·2026

Same journal

Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

The Journal of investigative dermatology·2026

Same journal

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 14, 2025

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

Deciphering Depigmentation: Mouse Models for Vitiligo Research.

Tyler J Long¹, Todd F Pearson², John E Harris²

¹Department of Dermatology, UMass Chan Medical School, Worcester, Massachusetts, USA; Department of Immunology, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School, Worcester, Massachusetts, USA.

The Journal of Investigative Dermatology

|July 24, 2025

Summary

This summary is machine-generated.

This review examines mouse models for vitiligo, an autoimmune skin disease causing depigmentation. Understanding these models is crucial for developing new vitiligo treatments and advancing research.

Keywords:

Autoimmunity Clinical research Models Mouse Vitiligo

More Related Videos

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

Related Experiment Videos

Last Updated: Sep 14, 2025

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

Area of Science:

Dermatology
Immunology
Genetics

Background:

Vitiligo is an autoimmune skin disease causing melanocyte loss and depigmentation.
Preclinical animal models are essential for understanding vitiligo pathogenesis and developing treatments.

Purpose of the Study:

To provide a comprehensive overview of established mouse models for vitiligo.
To categorize these models based on mechanisms of melanocyte loss, immune involvement, and human disease relevance.
To explore emerging research areas and the need for refined models.

Main Methods:

Literature review of established vitiligo mouse models.
Categorization of models based on disease mechanisms and relevance.
Critical evaluation of existing models for research application.

Main Results:

Established mouse models vary in their mechanisms of melanocyte loss and immune involvement.
Current models offer insights into vitiligo pathogenesis but have limitations in replicating human disease heterogeneity.
Emerging research highlights the need for more sophisticated models.

Conclusions:

Selection of appropriate mouse models is critical for advancing vitiligo research.
Refined models are needed to better mimic human vitiligo and predict therapeutic responses.
Continued development of preclinical models will drive novel treatment strategies.